
Blothin 250mg Tablet
Marketer
Indi Pharma
Salt Composition
Ticlopidine (250mg)
Overview Blothin 250mg Tablet
Clovix 250mg tablets are indicated for stroke prevention in patients unresponsive to or unsuitable for aspirin therapy. This antiplatelet agent, a blood thinner, reduces the risk of recurrent stroke following a prior stroke or transient ischemic attack (TIA). Clovix 250mg tablets inhibit harmful clot formation, thus preventing stroke. It may also be co-administered with aspirin post-angioplasty (stent placement) to mitigate stent thrombosis. Administer with food, ideally at the same time daily. Continuous use is crucial, even during symptom-free periods; discontinuation elevates stroke risk. Common adverse effects include nausea, vomiting, diarrhea, abdominal pain, rash, and leukopenia. Bleeding complications (bruising, epistaxis, hematuria, melena, or heavier menstrual bleeding) may occur; persistent or concerning bleeding warrants immediate medical attention. Clovix 250mg tablets are contraindicated in patients with active bleeding (e.g., peptic ulcer, intracranial hemorrhage), hepatic impairment, or hematological disorders (e.g., aplastic anemia, neutropenia). Pre-treatment and periodic complete blood counts (CBCs) are necessary. Temporary cessation may be required before elective surgery or dental procedures.
Primary Ingredients of Blothin 250mg Tablet
No text provided to rephrase.
Uses of Blothin 250mg Tablet
Preventing Cerebrovascular Accidents
Major Benefits of Blothin 250mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 250mg Blothin tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Blothin 250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain
- Rash
- Decreased white blood cell count
How to use Blothin 250mg Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the 250mg Blothin tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
How Blothin 250mg Tablet works:
Platelet aggregation is inhibited by the antithrombotic agent, Blothin 250mg Tablet. This action reduces the risk of dangerous clot development, consequently lowering the likelihood of cardiovascular events such as stroke or myocardial infarction.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Blothin 250mg Tablet is inadvisable.
PregnancySAFE IF PRESCRIBED
The use of Blothin 250mg Tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nonetheless, clinical data from human studies are scarce.
Breast feedingCONSULT YOUR DOCTOR
The use of Blothin 250mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a Blothin 250mg Tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving is discouraged if these side effects appear.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Blothin 250mg Tablet use in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Blothin 250mg tablets cautiously; dosage modification may be necessary. Liver function should be regularly assessed during treatment, and a physician's consultation is recommended.
What if you forget to take Blothin 250mg Tablet :
Should you forget to take a Blothin 250mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Blothin 250mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Thiopyridine analog |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | ADP receptor antagonists (P2Y12 inhibitors) |
